Dose ranging study
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
200
Unnamed facility
Beverly Hills, California, United States
Unnamed facility
San Diego, California, United States
Unnamed facility
New York, New York, United States
Unnamed facility
Raleigh, North Carolina, United States
Safety
physical exam, vital signs, clinical assessment of injection, clinical laboratory tests, and adverse events
Time frame: 8 weeks treatment
Change in abdominal circumference
abdominal circumference
Time frame: Baseline to 9 weeks
Change in global clinician scale score
Time frame: Baseline to 9 weeks
Change in global patient scale score
Time frame: Baseline to 9 weeks
Change in Photonumeric scale score
Time frame: Baseline to 9 weeks
Change in Patient Reported Outcome Score
Time frame: Baseline to 9 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Nashville, Tennessee, United States
Unnamed facility
Plano, Texas, United States